Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial
暂无分享,去创建一个
T. Hartman | L. Demers | A. Manni | K. El-Bayoumy | J. Richie | B. Prokopczyk | J. Liao | C. Signori | C. Hamilton | J. Liao | C. Dubrock | B. Prokopczyk | Jason Liao
[1] J. Liao,et al. Effects of fish oil and Tamoxifen on preneoplastic lesion development and biomarkers of oxidative stress in the early stages of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. , 2011, International journal of oncology.
[2] J. Russo,et al. Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations. , 2011, Cancer research.
[3] J. Liao,et al. The Effects of Tamoxifen and Fish Oil on Mammary Carcinogenesis in Polyoma Middle T Transgenic Mice , 2011, Hormones & cancer.
[4] R. Sinha,et al. Diet index-based and empirically derived dietary patterns are associated with colorectal cancer risk. , 2010, The Journal of nutrition.
[5] J. Philbrick,et al. Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Yan Li,et al. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. , 2010, The American journal of clinical nutrition.
[7] Richard D Bruggeman,et al. The Impact of Fish Oil on the Chemopreventive Efficacy of Tamoxifen against Development of N-Methyl-N-Nitrosourea–Induced Rat Mammary Carcinogenesis , 2010, Cancer Prevention Research.
[8] Erika A. Waters,et al. Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among U.S. Women , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[9] S. Hankinson,et al. Circulating 2-Hydroxy- and 16α-Hydroxy Estrone Levels and Risk of Breast Cancer among Postmenopausal Women , 2008, Cancer Epidemiology Biomarkers & Prevention.
[10] Norman Wolmark,et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. , 2006, JAMA.
[11] A. Neugut,et al. Relationship between Urinary 15-F2t-Isoprostane and 8-Oxodeoxyguanosine Levels and Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.
[12] Matthias Egger,et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.
[13] B. Ainsworth,et al. International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.
[14] D. Midthune,et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study. , 2001, American journal of epidemiology.
[15] B. Bonanni,et al. Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer , 2001, British Journal of Cancer.
[16] P. Lips,et al. Effects of the selective estrogen receptor modulator, raloxifene, on the somatotropic axis and insulin-glucose homeostasis. , 2001, The Journal of clinical endocrinology and metabolism.
[17] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[18] David J Hunter,et al. Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.
[19] W. Harris,et al. n-3 fatty acids and serum lipoproteins: animal studies. , 1997, The American journal of clinical nutrition.
[20] P. P. Toth,et al. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia , 2011 .
[21] John L Hopper,et al. Mammographic density: a heritable risk factor for breast cancer. , 2009, Methods in molecular biology.
[22] C. Ruxton,et al. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. , 2007, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[23] D. Yee,et al. Role of the IGF System in Breast Cancer Proliferation and Progression , 1999 .
[24] W. Harris,et al. n-3 fatty acids and serum lipoproteins: human studies. , 1997, The American journal of clinical nutrition.
[25] M. Osborne,et al. Omega-3 Fatty Acids: Modulation of Estrogen Metabolism and Potential for Breast Cancer Prevention , 1988 .
[26] C Slot,et al. Plasma creatinine determination. A new and specific Jaffe reaction method. , 1965, Scandinavian journal of clinical and laboratory investigation.